Emergence of new pathogens in CF: the devil we know or the devil we don't know?
Burns
Jane L
JL
D019072:Antibiotic Prophylaxis; D002506:Cephalexin / Q000627:therapeutic use*; D002511:Cephalosporins / Q000627:therapeutic use*; D003550:Cystic Fibrosis / Q000276:immunology / Q000382:microbiology*; D006801:Humans; D009894:Opportunistic Infections / Q000382:microbiology / Q000517:prevention & control*; D018410:Pneumonia, Bacterial / Q000209:etiology; D011023:Pneumonia, Staphylococcal / Q000517:prevention & control*; D011552:Pseudomonas Infections / Q000209:etiology
D002511:Cephalosporins; D002506:Cephalexin